Health Law Policy

  • Read more: State Concussion Legislation: Variable Implementation

    State Concussion Legislation: Variable Implementation

    By Christine Baugh The most recent issue of the Journal of Law Medicine and Ethics (generously made available for free by the American Society of Law Medicine and Ethics) included several articles examining state concussion laws. One theme that arose across the articles is that although concussion-related legislation is on the books in all 50 states and the…

  • Read more: Google Health Chats? Caveat Doctor

    Google Health Chats? Caveat Doctor

    By Nicolas Terry Recent speculation about healthcare disruption seems to have moved away from HIT to mHealth (discussed here). Apple has fueled this trend with its launch of sensor-laden iPhones and the new Apple Watch, iOS 8’s Health app and the HealthKit API framework. The future, we are told, is in mHealth provided by our phones…

  • Read more: The Response to Brittany Maynard

    The Response to Brittany Maynard

    By Lauren Taylor 29-year old Brittany Maynard has captured national headlines this week by publicly announcing her intention to end her own life on November 1st. She did so in an effort to raise funds for and awareness of the non-profit Compassion and Choices. Maynard was diagnosed earlier this year with an aggressive brain cancer…

  • Read more: Organ Transplantation: Legal and Ethical Challenges (EdX Course)

    Organ Transplantation: Legal and Ethical Challenges (EdX Course)

    By Pablo de Lora My university has recently joined EdX and is offering four courses starting February 2015. I have had the privilege of being selected as one of the instructors. I, along with Alicia Pérez Blanco (a skillful intensive care physician, wonderful colleague and sharp bioethicist), will be teaching a course on the ethical…

  • Read more: Ebola, Flight Bans, and Politics

    Ebola, Flight Bans, and Politics

    By Zachary Shapiro It seems like the debate over banning flights from West African Ebola stricken countries has become instantly political, with many Conservatives calling for a flight ban. See here. One author, in response to these calls, points to the history of Liberia’s relationship with the United States as a reason that the US…

  • Read more: Happy National Health Observances!

    Happy National Health Observances!

    By Emily Largent Perhaps you already knew that October is National Breast Cancer Awareness Month. Did you also know that it is: Domestic Violence Awareness Month, Eye Injury Prevention Month, Health Literacy Month, Home Eye Safety Month, National Bullying Prevention Month, National Down Syndrome Awareness Month, National Medical Librarians Month, National Physical Therapy Month, and…

  • Read more: Worth Reading This Week

    Worth Reading This Week

    By Nicolas Terry Jorge L. Contreras, Narratives of Gene Patenting, SSRN Sharona Hoffman, Citizen Science: The Law and Ethics of Public Access to Medical Big Data, SSRN/Berkeley Tech LJ James Hodge & Kellie Nelson, Active Shooters in Health Care Settings: Prevention and Response Through Law and Policy, SSRN/JLME David Orentlicher, Abortion and Compelled Physician Speech, SSRN/JLME

  • Read more: Rapid Rise in IND’s for Biosimilars

    Rapid Rise in IND’s for Biosimilars

    By Bob Bohrer [Cross-posted on Pharmaceutical Policy.] According to a story by Bronwyn Mixter in Bloomberg’s BNA BIOTECH WATCH, the FDA has received at least twenty-five IND’s for biosimilar development programs. Some quick perspective on that is appropriate. Twenty-five initial IND’s for the development of new small molecule drugs for cancer or autoimmune disease would face…

  • Read more: Congressmen Express Concern About Proposed Changes to Generic Drug Labeling Rules

    Congressmen Express Concern About Proposed Changes to Generic Drug Labeling Rules

    By Bob Bohrer I have previously posted on pharmaceuticalpolicy.blogspot.com about the FDA’s proposed change to the rules for generic drug labels and an estimate of the liability costs that might be incurred by the generic drug industry as a result of the proposed change.  The Generic Pharmaceutical Manufactuer’s Association lobbying efforts appear to have motivated…